VIIA

AcronymDefinition
VIIaVII zymogen into its active form
VIIAVirgin Islands Improvement Association
References in periodicals archive ?
CMC Biologics, which provides bioprocessing solutions to pharmaceutical and biotechnology companies, will develop, manufacture and supply Factor VIIa bulk drug substance for acute pulmonary administration for preCaeclinical and clinical studies as well as for commercialization on behalf of Serendex Pharmaceuticals.
LFB has been producing limited amounts of Factor VIIa in the milk of rabbits in France.
11,12) Treatment strategies to control active bleeding include the use of desmopressin (DDAVP), Factor VIII concentrate, activated prothrombin complex or APC (FEIBA - Anti-inhibitor coagulant factor), and Recombinant VIIa (NovoSeven).
Factor VIIa is a naturally occurring protein that plays an important role in the coagulation cascade.
GTC, together with its collaboration partner LFB Biotechnologies, has established the transgenic rabbit production system for its recombinant form of human coagulation factor VIIa (rhFVIIa) which is being developed for the treatment of patients with hemophilia.
In these instances a Factor VIIa is used to bypass inhibitors and help these individuals to form clots.
Key Words: recombinant factor VIIa, Crohn disease, surgery, bleeding, hemorrhage
NovoSeven Coagulation Factor VIIa (Recombinant) was approved in 1999 to treat bleeding episodes in hemophilia A or B patients with clotting inhibitors to Factor VIII or Factor IX.
Several years ago, Steel and her colleagues discovered that a mouse strain called shaker-1 owes its hearing loss to mutations in the gene for myosin VIIa.
Maxygen sold the recombinant factor VIIa product candidate (previously designated by Maxygen as MAXY-VII) to Bayer, together with its other hematology assets, in July 2008 for an upfront cash payment of $90.
OPKO) announced that it received a positive opinion from the European Committee for Orphan Medicinal Products (COMP), recommending the approval of orphan drug designation for OPKO's long-acting version of clotting Factor VIIa (Factor VIIa-CTP) for the treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX and the congenital Factor VII deficiency.
LFB SA and its Framingham-based subsidiary rEVO Biologics plan to build a colony of 1,000 to 1,200 rabbits making a protein called Factor VIIa at the farm, said Dr.